Clinical Trial: Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Symptomatic Chronic Middle Cerebral Artery Occlusion
Study Type: INTERVENTIONAL
Official Title: Extracranial-intracranial Bypass Surgery Versus Medical Treatment Alone for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
Brief Summary:
The CMOSS-2 trial is a government-funded, prospective, multicenter, randomized controlled trial.It will recruit symptomatic chronic occlusion of the middle cerebral artery in patients with severe hemodynamic insufficiency.Only high-volume center with a proven track record will be included.Patients will be randomized (1:1) to best medical treatment alone or medical treatment plus bypass surgery.Primary outcome is ischemic stroke in the territory of the target artery within 24 months after randomization.
Read more